BrightSpring Health Q3 revenue beats; raises 2026 revenue forecast
BTSG•BrightSpring Health’s third-quarter revenue rose 26% year over year to $4.21 billion, beating the $3.88 billion analyst estimate. The company raised its 2026 revenue forecast to $15.9 billion-$16.13 billion and expects adjusted EBITDA of $850 million-$860 million.
1. Quarterly results
Third-quarter adjusted EBITDA rose 42% year over year to $228 million, while gross profit was $519 million. BrightSpring attributed revenue growth to its Pharmacy Solutions and Provider Services segments.
2. Raised 2026 outlook
The company raised its 2026 revenue forecast to $15.9 billion-$16.13 billion and expects adjusted EBITDA of $850 million-$860 million. Amedisys and LHC branches are expected to add about $35 million to 2026 adjusted EBITDA.
3. Growth drivers
BrightSpring said Pharmacy Solutions revenue and gross profit per script increased significantly year over year. Higher average daily census in Home Health Care contributed to Provider Services revenue growth.
